TCTC Holdings’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$21K Hold
1,250
﹤0.01% 457
2025
Q1
$19.2K Hold
1,250
﹤0.01% 477
2024
Q4
$27.6K Hold
1,250
﹤0.01% 390
2024
Q3
$22.5K Hold
1,250
﹤0.01% 390
2024
Q2
$20.3K Sell
1,250
-625
-33% -$10.2K ﹤0.01% 401
2024
Q1
$26.5K Hold
1,875
﹤0.01% 367
2023
Q4
$19.6K Hold
1,875
﹤0.01% 379
2023
Q3
$19.1K Hold
1,875
﹤0.01% 327
2023
Q2
$14.1K Sell
1,875
-600
-24% -$4.52K ﹤0.01% 342
2023
Q1
$21.9K Hold
2,475
﹤0.01% 339
2022
Q4
$22.6K Hold
2,475
﹤0.01% 325
2022
Q3
$20K Hold
2,475
﹤0.01% 316
2022
Q2
$19K Hold
2,475
﹤0.01% 324
2022
Q1
$23K Sell
2,475
-450
-15% -$4.18K ﹤0.01% 321
2021
Q4
$23K Sell
2,925
-2,800
-49% -$22K ﹤0.01% 352
2021
Q3
$56K Sell
5,725
-2,176
-28% -$21.3K ﹤0.01% 294
2021
Q2
$78K Sell
7,901
-4,041
-34% -$39.9K ﹤0.01% 245
2021
Q1
$138K Sell
11,942
-900
-7% -$10.4K 0.01% 196
2020
Q4
$124K Sell
12,842
-439
-3% -$4.24K 0.01% 194
2020
Q3
$120K Sell
13,281
-1,100
-8% -$9.94K 0.01% 192
2020
Q2
$177K Buy
+14,381
New +$177K 0.01% 165
2017
Q2
Sell
-153,198
Closed -$4.92M 179
2017
Q1
$4.92M Buy
153,198
+30,974
+25% +$994K 0.3% 65
2016
Q4
$4.43M Buy
+122,224
New +$4.43M 0.27% 65
2016
Q3
Sell
-129,706
Closed -$6.52M 178
2016
Q2
$6.52M Sell
129,706
-600
-0.5% -$30.1K 0.44% 51
2016
Q1
$6.97M Sell
130,306
-12,900
-9% -$690K 0.44% 48
2015
Q4
$9.4M Sell
143,206
-800
-0.6% -$52.5K 0.56% 38
2015
Q3
$8.13M Sell
144,006
-6,223
-4% -$351K 0.46% 42
2015
Q2
$8.88M Buy
150,229
+9,225
+7% +$545K 0.51% 42
2015
Q1
$8.78M Sell
141,004
-7,350
-5% -$458K 0.52% 43
2014
Q4
$8.53M Sell
148,354
-12,200
-8% -$702K 0.52% 43
2014
Q3
$8.63M Buy
+160,554
New +$8.63M 0.5% 42
2014
Q2
Sell
-161,700
Closed -$8.54M 170
2014
Q1
$8.54M Sell
161,700
-35,167
-18% -$1.86M 0.49% 40
2013
Q4
$7.89M Buy
196,867
+23,731
+14% +$951K 0.45% 41
2013
Q3
$6.54M Sell
173,136
-14,001
-7% -$529K 0.42% 46
2013
Q2
$7.34M Buy
+187,137
New +$7.34M 0.48% 41